C-PEPTIDE STIMULATION BY GLUCAGON Test
Test cost: AED 980.0
Symptoms, Diagnosis, and Referring Details:
Test Name: C-PEPTIDE STIMULATION BY GLUCAGON Test
Components: Price: 980.0 AED
Sample Condition: 2 mL (0.5 mL min.) serum from 1 SST for each timed specimen. Draw baseline fasting specimen. Administer 1 mg Glucagon I.V. Draw additional specimens at 5, 10, and 15 minutes post-Glucagon. Note time drawn on each container label and test request form. 12 hours overnight fasting mandatory. Ship refrigerated or frozen.
Report Delivery: Daily
Method: Chemiluminescent Immunoassay
Test Type: Diabetes
Doctor: Endocrinologist, Physician
Test Department:
Pre Test Information: 12 hours overnight fasting mandatory. Injection Glucagon is not supplied by LPL.
Test Details:
The C-peptide stimulation by glucagon test is a diagnostic test used to evaluate the function of the beta cells in the pancreas. Beta cells are responsible for producing insulin, and C-peptide is a byproduct of insulin production. During the test, the patient is given an injection of glucagon, a hormone that stimulates the release of insulin from the beta cells. Blood samples are then taken at specific time intervals to measure the levels of C-peptide in the blood.
The test is typically performed in individuals with diabetes to determine if they are producing an adequate amount of insulin. If the C-peptide levels increase significantly after the glucagon injection, it indicates that the beta cells are functioning properly and producing insulin.
The C-peptide stimulation by glucagon test can help differentiate between type 1 and type 2 diabetes. In type 1 diabetes, the beta cells are destroyed and do not produce insulin, resulting in low C-peptide levels. In type 2 diabetes, the beta cells may still be functional, but insulin resistance leads to elevated blood glucose levels.
The test can help determine the underlying cause of diabetes and guide treatment decisions. It is important to note that the C-peptide stimulation by glucagon test should be performed under the supervision of a healthcare professional and is not suitable for all individuals. It may not be appropriate for individuals with certain medical conditions or those taking specific medications.
Additionally, the test results should be interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis.
| Test Name | C-PEPTIDE STIMULATION BY GLUCAGON Test |
|---|---|
| Components | |
| Price | 980.0 AED |
| Sample Condition | 2 mL (0.5 mL min.) serum from 1 SST for each timed specimen.Draw baseline fasting specimen. Administer 1 mg Glucagon I.V. Draw additional specimens at 5, 10 and 15 minutes post-Glucagon. Note time drawn on each container label and test request form. 12 hours overnight fasting mandatory. Ship refrigerated or frozen. |
| Report Delivery | Daily |
| Method | Chemiluminescent Immunoassay |
| Test type | Diabetes |
| Doctor | Endocrinologist, Physician |
| Test Department: | |
| Pre Test Information | 12 hours overnight fasting mandatory. Injection Glucagon is not supplied by LPL. |
| Test Details | The C-peptide stimulation by glucagon test is a diagnostic test used to evaluate the function of the beta cells in the pancreas. Beta cells are responsible for producing insulin, and C-peptide is a byproduct of insulin production. During the test, the patient is given an injection of glucagon, a hormone that stimulates the release of insulin from the beta cells. Blood samples are then taken at specific time intervals to measure the levels of C-peptide in the blood. The test is typically performed in individuals with diabetes to determine if they are producing an adequate amount of insulin. If the C-peptide levels increase significantly after the glucagon injection, it indicates that the beta cells are functioning properly and producing insulin. The C-peptide stimulation by glucagon test can help differentiate between type 1 and type 2 diabetes. In type 1 diabetes, the beta cells are destroyed and do not produce insulin, resulting in low C-peptide levels. In type 2 diabetes, the beta cells may still be functional, but insulin resistance leads to elevated blood glucose levels. The test can help determine the underlying cause of diabetes and guide treatment decisions. It is important to note that the C-peptide stimulation by glucagon test should be performed under the supervision of a healthcare professional and is not suitable for all individuals. It may not be appropriate for individuals with certain medical conditions or those taking specific medications. Additionally, the test results should be interpreted in conjunction with other clinical and laboratory findings to make an accurate diagnosis. |
